Evidence map›Paper›PMID 42173834›Full record

ArticleBlood cancer journal2026

Clinical outcomes of CD3xCD20 bispecific antibodies in patients with central nervous system involvement by lymphoma.

Karan L Chohan, Rina L Welkie, James Godfrey, Steven Bair, Lorenzo Falchi, Manali Kamdar, Ajay Major, Wendy Dixon, Jennifer Crombie, Reid Merryman and 9 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Blood cancer journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Karan L ChohanDepartment of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.ORCID http://orcid.org/0000-0003-1239-074X
Rina L WelkieDivision of Hematology, Department of Internal Medicine, Arthur G. James Comprehensive Cancer Center, The Ohio State University Wexner Medical Center, Columbus, OH, USA.ORCID http://orcid.org/0000-0001-9477-4581
James GodfreyCity of Hope, Hematology and Hematopoietic Cell Transplantation, Duarte, CA, USA.
Steven BairDivision of Hematology, University of Colorado-Anschutz Medical Campus, Aurora, CO, USA.
Lorenzo FalchiMemorial Sloan Kettering Cancer Center, New York, NY, USA.
Manali KamdarDivision of Hematology, University of Colorado-Anschutz Medical Campus, Aurora, CO, USA.
Ajay MajorDivision of Hematology, University of Colorado-Anschutz Medical Campus, Aurora, CO, USA.ORCID http://orcid.org/0000-0001-7261-1335
Wendy DixonDana-Farber Cancer Institute, Boston, MA, USA.
Jennifer CrombieDana-Farber Cancer Institute, Boston, MA, USA.
Reid MerrymanDana-Farber Cancer Institute, Boston, MA, USA.ORCID http://orcid.org/0000-0002-6360-3234
Sonia GodboleDivision of Hematology, Department of Internal Medicine, Arthur G. James Comprehensive Cancer Center, The Ohio State University Wexner Medical Center, Columbus, OH, USA.
Gilles SallesMemorial Sloan Kettering Cancer Center, New York, NY, USA.ORCID http://orcid.org/0000-0002-9541-8666
Omnia FarahatDepartment of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Amy AyersDepartment of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Ayushi ChauhanDepartment of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Alex HerreraCity of Hope, Hematology and Hematopoietic Cell Transplantation, Duarte, CA, USA.
Geoffrey ShouseCity of Hope, Hematology and Hematopoietic Cell Transplantation, Duarte, CA, USA.ORCID http://orcid.org/0000-0002-7917-5713
Sairah AhmedDepartment of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.ORCID http://orcid.org/0000-0001-7302-8299
Yazeed SawalhaDivision of Hematology, Department of Internal Medicine, Arthur G. James Comprehensive Cancer Center, The Ohio State University Wexner Medical Center, Columbus, OH, USA. yazeed.sawalha@osumc.edu.ORCID http://orcid.org/0000-0001-6355-3671

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42173834
PMCPMC13197401

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.